PRME Dividend History & Analysis | N/A Yield
PRME has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| Symbol | Market Cap (USD) | Dividend Yield TTM | Yield on Cost (purchase 5y ago) |
|---|---|---|---|
| JBIO | 280 M | 25.3% | 0.31% |
| ABBV | 403,129 M | 3.09% | 8.51% |
| GILD | 150,063 M | 2.57% | 6.41% |
| AMGN | 157,202 M | 3.17% | 4.74% |
| HLN | 41,279 M | 1.88% | 2.46% |
| Symbol | Market Cap (USD) | Growth Rate (CAGR) | Payout Consistency |
|---|---|---|---|
| GRFS | 8,004 M | 127% | 60.7% |
| HLN | 41,279 M | 51.0% | 100% |
| AMGN | 157,202 M | 8.90% | 100% |
| ABBV | 403,129 M | 7.06% | 100% |
| GILD | 150,063 M | 3.16% | 100% |
Similar Stocks with Attractive Dividends - Compare PRME Dividends with its Peer-Group
3.09% Yield
3.17% Yield
2.57% Yield
1.88% Yield
PRME Dividend History: as of November 2025
No dividends paid yet.PRME Dividend FAQ
Prime Medicine, Inc. (NASDAQ: PRME) is a U.S.-based biotech firm that focuses on delivering therapeutic gene edits using its proprietary Prime Editing platform, which combines a modified Cas protein, a reverse-transcriptase domain, and a pegRNA to rewrite DNA without creating double-stranded breaks. The company’s current collaboration with Cimeio Therapeutics targets “shielded-cell” and immunotherapy pairs for genetic disorders, acute myeloid leukemia (AML), and myelodysplastic syndrome (MDS). Incorporated in 2019 and headquartered in Cambridge, Massachusetts, PRME operates within the GICS Biotechnology sub-industry.
What is the Dividend Yield of PRME?
As of November 2025, PRME`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 4.56.Does PRME pay a dividend?
As of November 2025 PRME does not pay a dividend.How often does PRME pay dividends?
Over the last 12 months, PRME has issued dividend payments.Will PRME pay dividends in 2025?
The next Ex-Dividend date for Prime Medicine, Common (PRME) is currently unknown.What is the next Ex-Dividend Date for PRME?
The next Ex-Dividend date for Prime Medicine, Common (PRME) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of PRME?
PRME's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of PRME?
PRME's 5-Year Yield on Cost is -%. If you bought PRME's shares at 15.37 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of PRME?
PRME Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does PRME have a good Dividend Yield?
PRME`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of PRME?
The Dividend Payout Ratio of PRME is unknown.What is the Dividend Rating of PRME?
PRME`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield: Annual dividend per share divided by current share price.
- Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
- Payout Ratio: Percentage of earnings paid as dividends (TTM).
- Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
- Payout Frequency: Number of dividends paid in the last 12m (TTM).
- Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
- Total Return: Price appreciation plus dividends over specified period.
- Market Cap: Figures are in millions of the corresponding currency.
Last update: 2025-10-17 04:44